Rapid implementation of SARS-CoV-2 sequencing to investigate healthcare-associated COVID-19 infections: a genomic epidemiology study

This work was funded COG-UK, which is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute. It was also supported by the Wellcome (Senior Fellowship 207498/Z/17/Z and ARTIC Network Collaborative Award 206298/B/17/Z to IG, Collaborative Award 204870/Z/16/Z supporting CJH, Senior Research Fellowship to SGB 215515/Z/19/Z, Senior Clinical Research Fellowship 108070/Z/15/Z to MPW), the Academy of Medical Sciences and the Health Foundation (Clinician Scientist Fellowship to MET), and the National Institute for Health Research Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust (BW, GD, MET). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.